Peyronie's Disease
Patients' attitude with surgery for Peyronie's disease: results from a multicentric European study.
November 20, 2023
A survey of exposure to the use of Xiaflex for the treatment of Peyronie's disease among United States urology residency programs.
October 23, 2023
Serum testosterone concentration influences the response to extracorporeal shock wave treatment in men with Peyronie's disease.
October 16, 2023
What do patients with Peyronie's disease expect from therapy? A prospective multi-center study.
October 2, 2023
Updated recommendations on the therapeutic role of extracorporeal shock wave therapy for peyronie's disease: systematic review and meta-analysis.
September 18, 2023
European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie's disease.
September 11, 2023
Insurance approval rates for collagenase clostridium histolyticum prior to discontinuation: a Canada-wide analysis.
September 4, 2023
Low-intensity extracorporeal shockwave therapy for Peyronie's disease: An Indian experience.
August 28, 2023
Erectile dysfunction and Peyronie's disease diagnosis rates after penile fracture-a retrospective claims database cohort analysis.
August 7, 2023
In vitro efficacy of intralesional Collagenase Clostridium Histolyticum for the treatment of calcified Peyronie's disease plaques.
August 7, 2023
Non-surgical therapies for Peyronie's disease.
July 31, 2023